Skip to main content
Clinical Trials/JPRN-UMIN000054071
JPRN-UMIN000054071
Not yet recruiting
Phase 3

Optimizing Short-term Antibiotic Treatment in Acute Cholangitis: rationale and study protocol for an open-label randomized controlled trial - The BOLT-P3 Trial (Biliary Optimal Limited Treatment - Phase 3) - BOLT-P3

Shonan Kamakura General Hospital0 sites210 target enrollmentApril 9, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shonan Kamakura General Hospital
Enrollment
210
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2024
End Date
March 31, 2027
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Circulatory insufficiency with catecholamines at ERCP time. ICU need. Hypothermia below 35 degrees Celsius. Recurrent cholangitis within 3 months. Biliary stricture \>\= Bismuth 2 or unclear biliary block. Post\-surgery anatomical changes like biliary\-jejunal anastomosis. Pancreatitis per International Pancreatic Society/American Pancreatic Association: Upper abdominal pain, serum amylase/lipase \>3x ULN, acute pancreatitis imaging. Cholecystitis by TG18: A (Murphy's sign/right upper quadrant issues) \+ B (fever \>37\.1 degrees Celsius, CRP \>3\.0 mg/dL, WBC \>10,000 uL) \+ C (acute cholecystitis imaging). Hepatic abscess. Other infections. Pre\-registration continuous antibiotics. Pre\-registration ERCP complications (perforation, pancreatitis, bleeding, cholecystitis, sedation\-related issues). Immunosuppression: A (\>10 mg prednisolone), B (HIV), C (neutrophils \<\=1500 uL), D (recent hematopoietic stem cell transplantation). Pregnancy. Other exclusions by physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trialinfective endocarditisTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2019-003358-10-ESCarmen Olmos Blanco298
Active, not recruiting
Phase 1
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2014-001546-25-NLVU University Medical Center240
Completed
Phase 4
Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial.febrile neutropenia1001886510004018
NL-OMON47609VUmc276
Active, not recruiting
Phase 1
Optimizing the antibiotic treatment of uncomplicated acute appendicitisncomplicated acute appendicitisMedDRA version: 20.1Level: LLTClassification code 10000677Term: Acute appendicitisSystem Organ Class: 100000004862Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
EUCTR2015-003633-10-FITurku University Hospital552
Terminated
Not Applicable
STudy of Antibiotic Treatment In Children with chronic cough (STATIC)
ISRCTN88611534Royal Stoke University Hospital80